FK 3311 is primarily utilized in the field of medical research, particularly in the development of anti-inflammatory and analgesic drugs. It has shown potential in inhibiting the enzyme COX-2, which plays a key role in inflammation and pain pathways, making it a candidate for treating conditions like rheumatoid arthritis and other inflammatory disorders. Additionally, its application extends to preclinical studies where it is used to understand the biochemical mechanisms involved in inflammation and to evaluate the efficacy of new therapeutic agents. Researchers also explore its potential in combination therapies to enhance treatment outcomes for chronic inflammatory diseases and to reduce side effects associated with other NSAIDs.